Kinapse Appoints Shalabh Kumar as CEO

Share Article

Kinapse Ltd., provider of information processing and business consulting services to life sciences companies, announces that it has appointed Shalabh Kumar as the company's Chief Executive Officer, effective 1st February 2009. Shalabh is currently the Chief Operating Officer of the company and a member of the Board of Directors. He succeeds Andy Black who will continue serving as an Executive Director of the Board and in his new role will be the Global Head of Client Services.

Kinapse Ltd., provider of information processing and business consulting services to life sciences companies, announces that it has appointed Shalabh Kumar as the company's Chief Executive Officer, effective 1st February 2009. Shalabh is currently the Chief Operating Officer of the company and a member of the Board of Directors. He succeeds Andy Black who will continue serving as an Executive Director of the Board and in his new role will be the Global Head of Client Services.

Shalabh Kumar said, "It is an honour to be appointed the Chief Executive Officer of Kinapse. Since its founding in 2005, under Andy's leadership, the company has grown rapidly and established a reputation for very high quality service with our clients in the pharmaceutical and biotech industry. I strongly believe in the unique combination of expertise, collaboration, innovation and results that we bring to all our services and believe that is reflected in the success we have achieved to date. I look forward to leading the company in its next phase of growth as we continue to build Kinapse into a leader in information processing and consulting services to life sciences organisations."

Commenting on the appointment, Nicholas Edwards, Chairman of Kinapse, said, "I would like to thank Andy for his drive and energy in building up Kinapse into a strong business and I am very pleased that he will continue to lead client services globally through the next phase of our growth. I have worked with Shalabh for many years and am delighted that he has agreed to take on the leadership of Kinapse and build upon our strong foundation. The next years will be challenging ones for the pharmaceutical industry and I believe that under Shalabh's leadership Kinapse will continue to provide valued services to the world's leading life sciences organisations."

Additionally, Andy Black commented, "It has been a privilege to be the CEO of Kinapse for the last three and a half years and a pleasure to have shared the leadership of the company since its establishment. I am very proud of what our people have achieved and the excellent reputation that we have with our clients. I am delighted that the CEO role is now in Shalabh's capable hands and I look forward to continue working with him in my new role leading our portfolio of client services."

Shalabh Kumar Biography
Shalabh has 20 years of business consulting and operational management experience. His career includes R&D and strategy consulting with Kinapse and Accenture and operational management roles in Unilever and Gillette.

Shalabh co-founded Kinapse in 2005 and has been its Chief Operating Officer since inception. In this role, he has been responsible for strategic planning and implementation, managing the company operations across all locations and leading consulting and information processing projects.
Prior to Kinapse, Shalabh was in the strategy practice of Accenture in London, UK. Shalabh has also worked in the consumer goods industry in India and the US in various operational roles in brand and sales management.

Shalabh has a graduate degree in mechanical engineering from Indian Institute of Technology (IIT), Delhi and an MBA from Indian Institute of Management (IIM), Calcutta, where he graduated as a top 10 rank holder. He lives in London with his wife and two children.

About Kinapse
'Collaborating with our clients to innovate for exceptional results'

Kinapse provides business consulting and information processing services to life sciences organisations. Its clients include many of the world's leading pharmaceutical companies, leading biotechnology and specialty pharmaceutical companies, government organisations and industry service providers.

Headquartered in the UK, Kinapse has offices in London, New Delhi and Philadelphia, with partners based in the Americas, Europe and Asia Pacific. Kinapse blends expertise from its multiple locations to deliver services for clients at highest quality and differentiated value. The novel features of its operating model include:

  • blended onshore-offshore teams, tailored to client requirements;
  • industry-veteran Consulting Partners who bring deep experience and expertise in specific functional areas;
  • exclusive Service Partners with distinctive, complementary services.

Contact
Kathryn Turner
W: http://www.kinapse.com
P: +44 20 8946 7600

Kinapse Ltd.
Tuition House
27-37 St George's Road
Wimbledon
London SW19 4EU
UK

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kathryn Turner
Kinapse Ltd
+44 (0)20 8946 7600
Email >